Podcasts about broadening

Dr. Nathan Pennell and Dr. Cheryl Czerlanis discuss challenges in lung cancer screening and potential solutions to increase screening rates, including the use of AI to enhance risk prediction and screening processes. Transcript Dr. Nate Pennell: Hello, and welcome to By the Book, a monthly podcast series for ASCO Education that features engaging discussions between editors and authors from the ASCO Educational Book. I'm Dr. Nate Pennell, the co-director of the Cleveland Clinic Lung Cancer Program and vice chair of clinical research for the Taussig Cancer Center. I'm also the editor-in-chief for the ASCO Educational Book.  Lung cancer is one of the leading causes of cancer-related mortality worldwide, and most cases are diagnosed at advanced stages where curative treatment options are limited. On the opposite end, early-stage lung cancers are very curable. If only we could find more patients at that early stage, an approach that has revolutionized survival for other cancer types such as colorectal and breast cancer.  On today's episode, I'm delighted to be joined by Dr. Cheryl Czerlanis, a professor of medicine and thoracic medical oncologist at the University of Wisconsin Carbone Cancer Center, to discuss her article titled, "Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening." The article was recently published in the ASCO Educational Book and featured in an Education Session at the 2025 ASCO Annual Meeting. Our full disclosures are available in the transcript of this episode.  Cheryl, it's great to have you on the podcast today. Thanks for being here. Dr. Cheryl Czerlanis: Thanks, Nate. It's great to be here with you. Dr. Nate Pennell: So, I'd like to just start by asking you a little bit about the importance of lung cancer screening and what evidence is there that lung cancer screening is beneficial. Dr. Cheryl Czerlanis: Thank you. Lung cancer screening is extremely important because we know that lung cancer survival is closely tied to stage at diagnosis. We have made significant progress in the treatment of lung cancer, especially over the past decade, with the introduction of immunotherapies and targeted therapies based on personalized evaluation of genomic alterations. But the reality is that outside of a lung screening program, most patients with lung cancer present with symptoms related to advanced cancer, where our ability to cure the disease is more limited.  While lung cancer screening has been studied for years, the National Lung Screening Trial, or the NLST, first reported in 2011 a significant reduction in lung cancer deaths through screening. Annual low-dose CT scans were performed in a high-risk population for lung cancer in comparison to chest X-ray. The study population was comprised of asymptomatic persons aged 55 to 74 with a 30-pack-year history of smoking who were either active smokers or had quit within 15 years. The low-dose CT screening was associated with a 20% relative risk reduction in lung cancer-related mortality. A similar magnitude of benefit was also reported in the NELSON trial, which was a large European randomized trial comparing low-dose CT with a control group receiving no screening. Dr. Nate Pennell: So, this led, of course, to approval from CMS (Centers for Medicare and Medicaid Services) for lung cancer screening in the Medicare population, probably about 10 years ago now, I think. And there are now two major trials showing an unequivocal reduction in lung cancer-related mortality and even evidence that it reduces overall mortality with lung cancer screening. But despite this, lung cancer screening rates are very low in the United States. So, first of all, what's going on? Why are we not seeing the kinds of screening rates that we see with mammography and colonoscopy? And what are the barriers to that here? Dr. Cheryl Czerlanis: That's a great question. Thank you, Nate. In the United States, recruitment for lung cancer screening programs has faced numerous challenges, including those related to socioeconomic, cultural, logistical, and even racial disparities. Our current lung cancer screening guidelines are somewhat imprecise and often fail to address differences that we know exist in sex, smoking history, socioeconomic status, and ethnicity. We also see underrepresentation in certain groups, including African Americans and other minorities, and special populations, including individuals with HIV. And even where lung cancer screening is readily available and we have evidence of its efficacy, uptake can be low due to both provider and patient factors. On the provider side, barriers include having insufficient time in a clinic visit for shared decision-making, fear of missed test results, lack of awareness about current guidelines, concerns about cost, potential harms, and evaluating both true and false-positive test results.  And then on the patient side, barriers include concerns about cost, fear of getting a cancer diagnosis, stigma associated with tobacco smoking, and misconceptions about the treatability of lung cancer. Dr. Nate Pennell: I think those last two are really what make lung cancer unique compared to, say, for example, breast cancer, where there really is a public acceptance of the value of mammography and that breast cancer is no one's fault and that it really is embraced as an active way you can take care of yourself by getting your breast cancer screening. Whereas in lung cancer, between the stigma of smoking and the concern that, you know, it's a death sentence, I think we really have some work to be made up, which we'll talk about in a minute about what we can do to help improve this.  Now, that's in the U.S. I think things are probably, I would imagine, even worse when we leave the U.S. and look outside, especially at low- and middle-income countries. Dr. Cheryl Czerlanis: Yes, globally, this issue is even more complex than it is in the United States. Widespread implementation of low-dose CT imaging for lung cancer screening is limited by manpower, infrastructure, and economic constraints. Many low- and middle-income countries even lack sufficient CT machines, trained personnel, and specialized facilities for accurate and timely screenings. Even in urban centers with advanced diagnostic facilities, the high screening and follow-up care costs can limit access. Rural populations face additional barriers, such as geographic inaccessibility of urban centers, transportation costs, language barriers, and mistrust of healthcare systems. In addition, healthcare systems in these regions often prioritize infectious diseases and maternal health, leaving limited room for investments in noncommunicable disease prevention like lung cancer screening. Policymakers often struggle to justify allocating resources to lung cancer screening when immediate healthcare needs remain unmet. Urban-rural disparities exacerbate these challenges, with rural regions frequently lacking the infrastructure and resources to sustain screening programs. Dr. Nate Pennell: Well, it's certainly an intimidating problem to try to reduce these disparities, especially between the U.S. and low- and middle-income countries. So, what are some of the potential solutions, both here in the U.S. and internationally, that we can do to try to increase the rates of lung cancer screening? Dr. Cheryl Czerlanis: The good news is that we can take steps to address these challenges, but a multifaceted approach is needed. Public awareness campaigns focused on the benefits of early detection and dispelling myths about lung cancer screening are essential to improving participation rates. Using risk-prediction models to identify high-risk individuals can increase the efficiency of lung cancer screening programs. Automated follow-up reminders and screening navigators can also ensure timely referrals and reduce delays in diagnosis and treatment. Reducing or subsidizing the cost of low-dose CT scans, especially in low- or middle-income countries, can improve accessibility. Deploying mobile CT scanners can expand access to rural and underserved areas.  On a global scale, integrating lung cancer screening with existing healthcare programs, such as TB or noncommunicable disease initiatives, can enhance resource utilization and program scalability. Implementing lung cancer screening in resource-limited settings requires strategic investment, capacity building, and policy interventions that prioritize equity. Addressing financial constraints, infrastructure gaps, and sociocultural barriers can help overcome existing challenges. By focusing on cost-effective strategies, public awareness, and risk-based eligibility criteria, global efforts can promote equitable access to lung cancer screening and improve outcomes.  Lastly, as part of the medical community, we play an important role in a patient's decision to pursue lung cancer screening. Being up to date with current lung cancer screening recommendations, identifying eligible patients, and encouraging a patient to undergo screening often is the difference-maker. Electronic medical record (EMR) systems and reminders are helpful in this regard, but relationship building and a recommendation from a trusted provider are really essential here. Dr. Nate Pennell: I think that makes a lot of sense. I mean, there are technology improvements. For example, our lung cancer screening program at The Cleveland Clinic, a few years back, we finally started an automated best practice alert in our EMR for patients who met the age and smoking requirements, and it led to a six-fold increase in people referred for screening. But at the same time, there's a difference between just getting this alert and putting in an order for lung cancer screening and actually getting those patients to go and actually do the screening and then follow up on it. And that, of course, requires having that relationship and discussion with the patient so that they trust that you have their best interests. Dr. Cheryl Czerlanis: Exactly. I think that's important. You know, certainly, while technology can aid in bringing patients in, there really is no substitute for trust-building and a personal relationship with a provider. Dr. Nate Pennell: I know that there are probably multiple examples within the U.S. where health systems or programs have put together, I would say, quality improvement projects to try to increase lung cancer screening and working with their community. There's one in particular that you discuss in your paper called the "End Lung Cancer Now" initiative. I wonder if you could take us through that. Dr. Cheryl Czerlanis: Absolutely. "End Lung Cancer Now" is an initiative at the Indiana University Simon Comprehensive Cancer Center that has the vision to end suffering and death from lung cancer in Indiana through education and community empowerment. We discuss this as a paradigm for how community engagement is important in building and scaling a lung cancer screening program.  In 2023, the "End Lung Cancer Now" team decided to focus its efforts on scaling and transforming lung cancer screening rates in Indiana. They developed a task force with 26 experts in various fields, including radiology, pulmonary medicine, thoracic surgery, public health, and advocacy groups. The result of this work is an 85-page blueprint with key recommendations that any system and community can use to scale lung cancer screening efforts. After building strong infrastructure for lung cancer screening at Indiana University, they sought to understand what the priorities, resources, and challenges in their communities were. To do this, they forged strong partnerships with both local and national organizations, including the American Lung Association, American Cancer Society, and others. In the first year, they actually tripled the number of screening low-dose CTs performed in their academic center and saw a 40% increase system-wide. One thing that I think is the most striking is that through their community outreach, they learned that most people prefer to get medical care close to home within their own communities. Establishing a way to support the local infrastructure to provide care became far more important than recruiting patients to their larger system.  In exciting news, "End Lung Cancer Now" has partnered with the IU Simon Comprehensive Cancer Center and IU Health to launch Indiana's first and only mobile lung screening program in March of 2025. This mobile program travels around the state to counties where the highest incidence of lung cancer exists and there is limited access to screening. The mobile unit parks at trusted sites within communities and works in partnership, not competition, with local health clinics and facilities to screen high-risk populations. Dr. Nate Pennell: I think that sounds like a great idea. Screening is such an important thing that it doesn't necessarily have to be owned by any one particular health system for their patients. I think. And I love the idea of bringing the screening to patients where they are. I can speak to working in a regional healthcare system with a main campus in the downtown that patients absolutely hate having to come here from even 30 or 40 minutes away, and they'd much rather get their care locally. So that makes perfect sense.  So, under the current guidelines, there are certainly things that we can do to try to improve capturing the people that meet those. But are those guidelines actually capturing enough patients with lung cancer to make a difference? There certainly are proposals within patient advocacy communities and even other countries where there's a large percentage of non-smokers who perhaps get lung cancer. Can we expand beyond just older, current and heavy smokers to identify at-risk populations who could benefit from screening? Dr. Cheryl Czerlanis: Yes, I think we can, and it's certainly an active area of research interest. We know that tobacco is the leading cause of lung cancer worldwide. However, other risk factors include secondhand smoke, family history, exposure to environmental carcinogens, and pulmonary diseases like COPD and interstitial lung disease. Despite these known associations, the benefit of lung cancer screening is less well elucidated in never-smokers and those at risk of developing lung cancer because of family history or other risk factors. We know that the eligibility criteria associated with our current screening guidelines focus on age and smoking history and may miss more than 50% of lung cancers. Globally, 10% to 25% of lung cancer cases occur in never-smokers. And in certain parts of the world, like you mentioned, Nate, such as East Asia, many lung cancers are diagnosed in never-smokers, especially in women. Risk-prediction models use specific risk factors for lung cancer to enhance individual selection for screening, although they have historically focused on current or former smokers.  We know that individuals with family members affected by lung cancer have an increased risk of developing the disease. To this end, several large-scale, single-arm prospective studies in Asia have evaluated broadening screening criteria to never-smokers, with or without additional risk factors. One such study, the Taiwan Lung Cancer Screening in Never-Smoker Trial, was a multicenter prospective cohort study at 17 medical centers in Taiwan. The primary outcome of the TALENT trial was lung cancer detection rate. Eligible patients aged 55 to 75 had either never smoked or had a light and remote smoking history. In addition, inclusion required one or more of the following risk factors: family history of lung cancer, passive smoke exposure, history of TB or COPD, a high cooking index, which is a metric that quantifies exposure to cooking fumes, or a history of cooking without ventilation. Participants underwent low-dose CT screening at baseline, then annually for 2 years, and then every 2 years for up to 6 years. The lung cancer detection rate was 2.6%, which was higher than that reported in the NLST and NELSON trials, and most were stage 0 or I cancers. Subsequently, this led to the Taiwan Early Detection Program for Lung Cancer, a national screening program that was launched in 2022, targeting 2 screening populations: individuals with a heavy history of smoking and individuals with a family history of lung cancer.  We really need randomized controlled trials to determine the true rates of overdiagnosis or finding cancers that would not lead to morbidity or mortality in persons who are diagnosed, and to establish whether the high lung detection rates are associated with a decrease in lung cancer-related mortality in these populations. However, the implementation of randomized controlled low-dose CT screening trials in never-smokers has been limited by the need for large sample sizes, lengthy follow-up, and cost.  In another group potentially at higher risk for developing lung cancer, the role of lung cancer screening in individuals who harbor germline pathogenic variants associated with lung cancer also needs to be explored further. Dr. Nate Pennell: We had this discussion when the first criteria came out because there have always been risk-based calculators for lung cancer that certainly incorporate smoking but other factors as well and have discussion about whether we should be screening people based on their risk and not just based on discrete criteria such as smoking. But of course, the insurance coverage for screening, you have to fit the actual criteria, which is very constrained by age and smoking history. Do you think in the U.S. there's hope for broadening our screening beyond NLST and NELSON criteria? Dr. Cheryl Czerlanis: I do think at some point there is hope for broadening the criteria beyond smoking history and age, beyond the criteria that we have typically used and that is covered by insurance. I do think it will take some work to perhaps make the prediction models more precise or to really understand who can benefit. We certainly know that there are many patients who develop lung cancer without a history of smoking or without family history, and it would be great if we could diagnose more patients with lung cancer at an earlier stage. I think this will really count on there being some work towards trying to figure out what would be the best population for screening, what risk factors to look for, perhaps using some new technologies that may help us to predict who is at risk for developing lung cancer, and trying to increase the group that we study to try and find these early-stage lung cancers that can be cured. Dr. Nate Pennell: Part of the reason we, of course, try to enrich our population is screening works better when you have a higher pretest probability of actually having cancer. And part of that also is that our technology is not that great. You know, even in high-risk patients who have CT scans that are positive for a screen, we know that the vast majority of those patients with lung nodules actually don't have lung cancer. And so you have to follow them, you have to use various models to see, you know, what the risk, even in the setting of a positive screen, is of having lung cancer.  So, why don't we talk about some newer tools that we might use to help improve lung cancer screening? And one of the things that everyone is super excited about, of course, is artificial intelligence. Are there AI technologies that are helping out in early detection in lung cancer screening? Dr. Cheryl Czerlanis: Yes, that's a great question. We know that predicting who's at risk for lung cancer is challenging for the reasons that we talked about, knowing that there are many risk factors beyond smoking and age that are hard to quantify. Artificial intelligence is a tool that can help refine screening criteria and really expand screening access. Machine learning is a form of AI technology that is adept at recognizing patterns in large datasets and then applying the learning to new datasets. Several machine learning models have been developed for risk stratification and early detection of lung cancer on imaging, both with and without blood-based biomarkers. This type of technology is very promising and can serve as a tool that helps to select individuals for screening by predicting who is likely to develop lung cancer in the future.  A group at Massachusetts General Hospital, represented in our group for this paper by my co-authors, Drs. Fintelmann and Chang, developed Sybil, which is an open-access 3D convolutional neural network that predicts an individual's future risk of lung cancer based on the analysis of a single low-dose CT without the need for human annotation or other clinical inputs. Sybil and other machine learning models have tremendous potential for precision lung cancer screening, even, and perhaps especially, in settings where expert image interpretation is unavailable. They could support risk-adapted screening schedules, such as varying the frequency and interval of low-dose CT scans according to individual risk and potentially expand lung cancer screening eligibility beyond age and smoking history. Their group predicts that AI tools like Sybil will play a major role in decoding the complex landscape of lung cancer risk factors, enabling us to extend life-saving lung cancer screening to all who are at risk. Dr. Nate Pennell: I think that that would certainly be welcome. And as AI is working its way into pretty much every aspect of life, including medical care, I think it's certainly promising that it can improve on our existing technology.  We don't have to spend a lot of time on this because I know it's a little out of scope for what you covered in your paper, but I'm sure our listeners are curious about your thoughts on the use of other types of testing beyond CT screening for detecting lung cancer. I know that there are a number of investigational and even commercially available blood tests, for example, for detection of lung cancer, or even the so-called multi-cancer detection blood tests that are now being offered, although not necessarily being covered by insurance, for multiple types of cancer, but lung cancer being a common cancer is included in that. So, what do you think? Dr. Cheryl Czerlanis: Yes, like you mentioned, there are novel bioassays such as blood-based biomarker testing that evaluate for DNA, RNA, and circulating tumor cells that are both promising and under active investigation for lung cancer and multi-cancer detection. We know that such biomarker assays may be useful in both identifying lung cancers but also in identifying patients with a high-risk result who should undergo lung cancer screening by conventional methods. Dr. Nate Pennell: Anything that will improve on our rate of screening, I think, will be welcome. I think probably in the future, it will be some combination of better risk prediction and better interpretation of screening results, whether those be imaging or some combination of imaging and biomarkers, breath-based, blood-based. There's so much going on that it is pretty exciting, but we're still going to have to overcome the stigma and lack of public support for lung cancer screening if we're going to move the needle. Dr. Cheryl Czerlanis: Yes, I think moving the needle is so important because we know lung cancer is still a very morbid disease, and our ability to cure patients is not where we would like it to be. But I do believe there's hope. There are a lot of motivated individuals and groups who are passionate about lung cancer screening, like myself and my co-authors, and we're just happy to be able to share some ways that we can overcome the challenges and really try and make an impact in the lives of our patients. Dr. Nate Pennell: Well, thank you, Dr. Czerlanis, for joining me on the By the Book Podcast today and for all of your work to advance care for patients with lung cancer. Dr. Cheryl Czerlanis: Thank you, Dr. Pennell. It's such a pleasure to be with you today. Thank you. Dr. Nate Pennell: And thank you to our listeners for joining us today. You'll find a link to Dr. Czerlanis' article in the transcript of this episode.  Please join us again next month for By the Book's next episode and more insightful views on topics you'll be hearing at the education sessions from ASCO meetings throughout the year, and our deep dives on approaches that are shaping modern oncology. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:     Dr. Nathan Pennell    @n8pennell   @n8pennell.bsky.social Dr. Cheryl Czerlanis Follow ASCO on social media:     @ASCO on X (formerly Twitter)     ASCO on Bluesky    ASCO on Facebook     ASCO on LinkedIn     Disclosures:    Dr. Nate Pennell:        Consulting or Advisory Role: AstraZeneca, Lilly, Cota Healthcare, Merck, Bristol-Myers Squibb, Genentech, Amgen, G1 Therapeutics, Pfizer, Boehringer Ingelheim, Viosera, Xencor, Mirati Therapeutics, Janssen Oncology, Sanofi/Regeneron       Research Funding (Institution): Genentech, AstraZeneca, Merck, Loxo, Altor BioScience, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Jounce Therapeutics, Mirati Therapeutics, Heat Biologics, WindMIL, Sanofi    Dr. Cheryl Czerlanis: Research Funding (Institution): LungLife AI, AstraZeneca, Summit Therapeutics

After two years of full steam ahead for U.S. equity markets, 2025 has so far featured a number of speed bumps and even a few U-turns for some key areas of the market. With continued market volatility and a stock market correction, how should investors be thinking about the U.S. equity market as compared with the rest of the world?Carrie King, U.S. and Developed Markets Chief Investment Officer for BlackRock's Fundamental Equities group will discuss market volatility, rotations and the state of the U.S. equity market.Sources: Q2 Equities Outlook, BlackRock 2025Check out the full series covering tariffs and market volatility on The Bid: https://open.spotify.com/playlist/3iiZbbNz3eI08zXGZ4n3LI?si=TNiOrYRoSxyXVsbwsBs68QKey moments in this episode:00:00 Introduction to Market Volatility and The Equity Landscape02:00 Recap of Previous Discussion and Market Trends03:48 Broadening of the Equity Markets04:27 US vs. Global Market Performance05:13 Drivers of Market Rotation and Volatility06:28 Fundamental Shifts in the Market09:15 European Market Outperformance12:11 US Exceptionalism and Future Outlook15:11 Health of US Corporations and Consumers18:14 Investor Sentiment and Future Outlook19:20 Conclusion and Investor Takeaways

Join Dr. Stephanie and Dr. Saulnier as they discuss her presentation at the Converge Autism Summit on broadening the autism spectrum.https://nacsatl.com/They will discuss:The key features of autismHow Autism symptoms are expressed differently in male and femaleThe role of racial, ethnic, and socioeconomic disparities in misdiagnosis of autismCommon overlaps and differential diagnosisDr. Saulnier obtained her doctorate in Clinical Psychology from the University of Connecticut. She trained and worked at the Yale Child Study Center's Autism Program for nearly a decade before relocating to Emory University School of Medicine and the Marcus Autism Center in Atlanta, GA, where she directed a large-scale clinical research program. In 2018, she opened her own company, Neurodevelopmental Assessment & Consulting Services, where she specializes in diagnostic assessment, as well as teaching and training for autism spectrum and related disorders. Dr. Saulnier has published over 50 articles, written two books, and she is an author on the Vineland Adaptive Behavior Scales, Third Edition.Looking for Assessment in GA? https://www.psychologytoday.com/us/therapists/neurodevelopmental-assessment-consulting-svc-decatur-ga/409874

This week's episode with Rabbanit Surale Rosen closes our series on the lived experience of Torah observance.The conversation begins with an idea rooted in our parsha regarding an ethic that may have preceded the official giving of Torah and continues on to explore some of the tensions between Halakhic life and secular sensibilities both in Israel and abroad. When does applying a halakhic frame feel absurd? How might broadening the purview of halakha actually help make its observance more organic? This week's episode has been sponsored in memory of Vita Rachel bat Yaacov Bradfield z"l. Our upcoming Bamidbar series will focus on issues of leadership--Chazak, Chazak, V'nitchazek!

 His Week That Was – Kevin Healy Update on the Gaza flotilla ship which was bombed by Israel in international waters – Ann Wright US human rights activist waiting on shore to board, US activist for Palestine Cassandra Dixon talking about her 20 years of periodically protecting children and farmers in the West Bank against settlers, Nic Maclellan, journalist with Islands Business looking back on Biden and forward to Trump regarding Pacific nations, Dr Sue Wareham (MAPW) & Professor Emeritus Stuart Rees analyzing the election results, Executive Director of GeneEthics Network, Bob Phelps with latest on attempts to broaden genetic engineering in Australia. Head to www.3cr.org.au/hometime-tuesday for full access to links and previous podcasts 

As part of the ongoing efforts to attract more people into the accounting profession, there are legislative efforts in New Jersey and across the country to create an additional pathway to CPA licensure. Get an update on where things stand and what's included in the legislation. Resources:CPA Pipeline Knowledge HubNJ-CPA-Political Action Committee

In today's episode, we tackle one of the biggest tensions modern clinicians face:How do you keep your schedule full and patients engaged without fear-mongering or overselling?I share how to reframe “sales” from manipulation to alignment, why selling your services is an ethical obligation, and how to transition from just treating pain to guiding patients toward long-term health and resilience.If you've ever felt stuck between wanting to do right by your patients and keeping your business thriving — this one's for you.➡️ Learn how to out-value, not out-volume, the competition.➡️ Find out why selling real wellness is the future.➡️ Hear real-world strategies to build relationships, not dependency.**Timestamps**00:00 Introduction and Episode Overview00:09 Listener's Message and Common Struggles00:44 Reframing Sales in Healthcare01:10 Personal Journey with Sales02:20 Ethical Sales and Value Exchange04:54 Challenges with the Fix Model07:13 Broadening the Scope of Care14:08 Practical Tips for Ethical Sales17:12 Conclusion and Call to ActionSubscribe for more episodes:  https://youtube.com/@modernpainpodcastConnect with me:Website: https://modernpaincare.comInstagram: @modernpaincareEmail: mark@modernpaincare.com*********************************************************************

Jerome Upton still remembers the silence that descends just before a game begins. As captain of his college team, he'd scan the huddle, gauge nerves, and ask, “What does winning look like today?” “That's where I learned the power of shared goals,” Upton tells us. Years later, the Genworth Financial CFO opens staff meetings similarly—then hands teammates room to execute.The first bold play of his career came soon after graduation. At a small insurer, Upton stunned mentors by jumping to KPMG. “I needed wider fields,” he explains. Eight years of audits sharpened his technical vision, yet the move that truly stretched him arrived when GE Capital—Genworth's predecessor—offered a divisional‑controller seat with global scope. Overnight his “team” expanded ten‑fold, teaching him to win through trust rather than touch‑every‑file oversight.International assignments followed: boardrooms in Europe, investor roadshows in Asia, client visits in Latin America. Hearing customers critique products in real time “made finance feel less like a ledger and more like a heartbeat,” he says. That perspective proved vital during Genworth's post‑crisis crossroads. Tasked with raising capital quickly, Upton orchestrated a minority IPO of a foreign subsidiary, executed at speed and premium valuation. The deal slashed leverage and revealed hidden asset value.Today his playbook balances share buybacks and debt reduction with growth bets such as CareScout. Multi‑year downside modeling safeguards the core, while his Gretzkyesque mantra—skate where the puck is going—keeps him focused on tomorrow's opportunity.

For episode 262, Sharon speaks with Scott Barry Kaufman as part of the Metta Hour Anxiety Series.In this series, Sharon is speaking with Mental Health experts, providers and researchers for tools to work with anxiety in increasingly challenging times. Dr. Scott Barry Kaufman, Ph.D., is a cognitive scientist and humanistic psychologist exploring the depths of human potential. He is founder of the Center for Human Potential and founder of Self-Actualization Coaching. Scott is the author of eleven books, including Rise Above, his forthcoming book set for release in 2025. Scott is also host of The Psychology Podcast— which has received over 30 million downloads. In this conversation, Sharon and Scott speak about:• Having growth motivation• Shifting the narrative of anxiety• Scott's childhood experiences• Curiosity versus grit• How to shift out of fear• Creating space around anxiety• Welcoming our beautiful monsters• Broadening the Window of Tolerance• Experiencing a sense of bothness• Scott's new book, Rise Above• Victim versus empowerment mindset• Learned Hopefulness• Finding the light within• Pros and cons of sensitivity• The blessings of gratitude and aweThe episode closes with Scott leading a Tonglen practice.You can learn more about Scott's work right here and check out his new book, Rise Above, right here.Check out the first two episodes in the Anxiety Podcast Series with Dr. Jud Brewer right here and Dr. Jenny Taitz right here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"Episode 624" centers on the biblical passage of 1 Corinthians 13, often called the "love chapter." Analyzing the definition of love presented in this text, emphasizing qualities like patience and kindness, while contrasting them with negative behaviors. Broadening the application of this passage beyond romantic relationships to encompass all interactions among people. Discussing the importance of logical, respectful communication rooted in love, contrasting it with emotionally driven arguments prevalent in society. Ultimately, encouraging to reflect on these principles and strive to embody them in our daily lives and relationships.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-gospel-road-with-jimmy-olsen--1155987/support.

On a new TAGS LIVE aka Talk About Gay Sex podcast the live edition Host Stevie V and Co-host Kodi Maurice Doggette are back with all new hot LGBTQ topics, sex and relationship advice and more in front of live virtual audience:Saying goodbye to Adult Performer Damien StoneThe Vivienne died of Ketamine and the push to make it a riskier drug that's taking too many of our community...Gay prominent yoga instructor, Marcus Frieber found dead in a quarry...it just doesn't add up!Why Chemsex is really dangerous and why many aren't even aware of it...'Mid-Century Modern' will not be political but it may tackle some serious issues...Troye Sivan mourns the end of poppers?No 'U Turn' Signs in the Silver Lake area of LA mark the end of discrimination for our communityWhy you should consider getting a HPV vaccination...Dating Apps and privacy disaster to the most marginalized communities...something has to change!It's time to broaden you and your partner's sexual horizons!Advice: having multiple FWB's?Support TAGS and get extra special perks! New Bonus Episode for 2025 out now! Patreon.com/tagspodcastGrab a tier or get our Free Tier and get Behind the Scenes content plus you can now purchase individual content!Follow Steve V. on IG: @iam_stevevhttps://linktr.ee/kodimauricehttps://linktr.ee/kodimauriceFollow Kodi's Life Coaching on IG: @kmdcoachingFollow Kodi Maurice Doggette on IG: @mistahmauriceWanna drop a weekly or one time tip to TAGSPODCAST - Show your love for the show and support TAGS! Visit our website: tagspodcast.comNeeds some advice for a sex or relationship conundrum? Ask TAGS! DM US ON IG or https://www.talkaboutgaysex.com/contactFollow Of a Certain Age on IG: @ofacertainagepod

Who is Dr Anji Sinha? Our US bureau chief finds that the key to this story lies in relationships. Synopsis: Every third Friday of the month, The Straits Times gets its US Bureau Chief to analyse the hottest political and trending talking points. As of the publication of this episode on March 21, nothing much is known about the person recently nominated by US President Donald Trump to become the top American diplomat in Singapore beyond his or her name. The Straits Times’ senior columnist Lin Suling and US bureau chief Bhagyashree Garekar reveal the detective work involved in trying to uncover who US President Donald Trump’s nominee for US Ambassador to Singapore is - from following the breadcrumbs laid out by contacts to dealing with dead ends and working the phones to reveal the Florida connection. Highlights (click/tap above): 03:00 The significance of the US Ambassador to Singapore 04:55 Uncovering who Dr Anji Sinha is 07:34 A tip-off and a subtle hint 09:53 Dealing with hesitant sources, sensitive diplomatic matters 14:17 Broadening contacts 17:28 The Trump administration’s cautious approach 19:46 The Florida Connection 25:02 Looking ahead: The confirmation process Read Bhagyashree Garekar’s articles: https://str.sg/whNo Read Lin Suling’s articles: https://str.sg/nnEQ Follow Lin Suling on LinkedIn: https://str.sg/t2RX Read Clement Tan's articles: https://str.sg/Ep62 Follow Clement Tan on X: https://str.sg/uErS Register for Asian Insider newsletter: https://str.sg/stnewsletters Host: Lin Suling (linsuling@sph.com.sg) Produced and edited by: Fa’izah Sani Executive producer: Ernest Luis Follow Asian Insider Podcast on Fridays here: Channel: https://str.sg/JWa7 Apple Podcasts: https://str.sg/JWa8 Spotify: https://str.sg/JWaX Feedback to: podcast@sph.com.sg --- Follow more ST podcast channels: All-in-one ST Podcasts channel: https://str.sg/wvz7 ST Podcasts website: http://str.sg/stpodcasts ST Podcasts YouTube: https://str.sg/4Vwsa --- Get The Straits Times app, which has a dedicated podcast player section: The App Store: https://str.sg/icyB Google Play: https://str.sg/icyX --- #STAsianInsiderSee omnystudio.com/listener for privacy information.

Who is Dr Anji Sinha? Our US bureau chief finds that the key to this story lies in relationships. Synopsis: Every third Friday of the month, The Straits Times gets its US Bureau Chief to analyse the hottest political and trending talking points. As of the publication of this episode on March 21, nothing much is known about the person recently nominated by US President Donald Trump to become the top American diplomat in Singapore beyond his or her name. The Straits Times’ senior columnist Lin Suling and US bureau chief Bhagyashree Garekar reveal the detective work involved in trying to uncover who US President Donald Trump’s nominee for US Ambassador to Singapore is - from following the breadcrumbs laid out by contacts to dealing with dead ends and working the phones to reveal the Florida connection. Highlights (click/tap above): 03:00 The significance of the US Ambassador to Singapore 04:55 Uncovering who Dr Anji Sinha is 07:34 A tip-off and a subtle hint 09:53 Dealing with hesitant sources, sensitive diplomatic matters 14:17 Broadening contacts 17:28 The Trump administration’s cautious approach 19:46 The Florida Connection 25:02 Looking ahead: The confirmation process Read Bhagyashree Garekar’s articles: https://str.sg/whNo Read Lin Suling’s articles: https://str.sg/nnEQ Follow Lin Suling on LinkedIn: https://str.sg/t2RX Read Clement Tan's articles: https://str.sg/Ep62 Follow Clement Tan on X: https://str.sg/uErS Register for Asian Insider newsletter: https://str.sg/stnewsletters Host: Lin Suling (linsuling@sph.com.sg) Produced and edited by: Fa’izah Sani Executive producer: Ernest Luis Follow Asian Insider Podcast on Fridays here: Channel: https://str.sg/JWa7 Apple Podcasts: https://str.sg/JWa8 Spotify: https://str.sg/JWaX Feedback to: podcast@sph.com.sg --- Follow more ST podcast channels: All-in-one ST Podcasts channel: https://str.sg/wvz7 ST Podcasts website: http://str.sg/stpodcasts ST Podcasts YouTube: https://str.sg/4Vwsa --- Get The Straits Times app, which has a dedicated podcast player section: The App Store: https://str.sg/icyB Google Play: https://str.sg/icyX --- #STAsianInsiderSee omnystudio.com/listener for privacy information.

Host Katy Ganaway facilitates a panel of film enthusiasts: KB of KBS VHS, Josh Jossey of Schlockbuster Presents, & Rob Freese of The Mad Movie-A-Thon-O-Rama.

International law recognizes the importance of environmental protection during armed conflict. Additional Protocol I of the Geneva Conventions was the first treaty to formally prohibit warfare methods that cause widespread, long-term, and severe environmental damage. The Rome Statute of the International Criminal Court (ICC) further criminalizes damage to the natural environment as a war crime, though its high threshold has so far prevented its use. The existing initiatives to define “ecocide” aim, among other things, to broaden accountability beyond armed conflict and include corporations. In this post, part of the Emerging Voices series, Iryna Rekrut, Legal Fellow at the Center for Gender & Refugee Studies, proposes an additional potential avenue that could also be used to improve accountability for environmental damage under the Rome Statute. She argues that a more expansive interpretation of existing provisions – particularly refining the definitions of “widespread,” “long-term,” and “severe” damage – could meet the evidentiary burden and make prosecution more viable under current international law.

Scott Bauer looks at the U.S. dollar moving lower and the current market breadth. He also examines copper futures after their recent rise.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

You are listening to the messages from Pastor Scott Tewell who is the Lead Pastor at Rosedale Baptist Church in Rosedale, MD. Each week we provide these messages to help you grow in your faith and find encouragement through God's Word.

On this Company episode of The Synopsis we draw on our 75-page research report on Axon Enterprises, a leading law enforcement technology provider, for a very in-depth break down of the company. Founder Rick Smith took a failed concept—the TASER—and not only created a succesful business around it, but made it become a mainstay of policing. Not content to just reinvent how policing worked in the field, Axon pushed into other critical areas of law enforcement like officer video, cloud-based data management, and vertical software. A 1,000x return since going public in 2001, Axon is one of the highest returning stocks of all time. But more interesting than the investment returns, is all of the lessons we can learn from Billionaire Founder Rick Smith.  Learn more about our 75-page research report here.  For full access to all of our in-depth research reports, become a Speedwell Member here.  If you need help getting Speedwell Research to become an approved research vendor, so you can expense your subscription, please email info@speedwellresearch.com  *~*~*~* Mentioned Speedwell Memos:  Minimum Viable Products versus Maximum Possible Products How Axon's Founder Built a $35bn Business: 10 Lessons from Rick Smith -*-*-*-*-*-*-*-*-*-*- Show Notes Part 1: Founding History and Background (0:00) Axon Overview (3:34) — Background of the Advent of the TASER (12:08)— Rick Smith Reinvents the TASER and the Founding of AirTaser (15:39) — AirTaser Early Struggles (23:20) — Taser International rename, Going Public (34:36) — Broadening their Mission and Product Lines, Introducing Axon (43:47) — R&D Fumbles, Importance of Knowing when to Iterate vs Innovate (51:11) — Axon Camera Business Frictions,  Gaining Adoption and Building a Competitive Moat (1:17:57) — Concluding History *~* Part 2: Financials, Industry, Competition, and Valuation (1:26:22) — Revenue Segments, Business Model (1:43:39) — Profitability and Mature Margins (1:47:45) — Industry and TAM, Pricing Power (1:57:59) — Competition (2:29:38) — Why Axon Wins (One Breath Take) (2:33:36) — ROIC, Mature Profitability, Free Cash Flow (2:40:51) — Valuation (2:44:07) — Risks (2:49:01) — Free Axon Resources from Speedwell -*-*-*-*-*-*-*-*-*-*- Become a Speedwell Member here to gain access to *all* of our in-depth research reports and more!   Sign up for Speedwell's free newsletter and weekly memos here *-*-*- Follow Us: Twitter: @Speedwell_LLC Threads: @speedwell_research Email us at info@speedwellresearch.com for any questions, comments, or feedback. -*-*-*-*-*-*-*-*-*-*- Disclaimer Nothing in this podcast is investment advice nor should be construed as such. Contributors to the podcast may own securities discussed. Furthermore, accounts contributors advise on may also have positions in companies discussed. At the time of recording contributors had a position in Perimeter Solutions. Furthermore, accounts contributors advise on also may have  a position in Perimeter Solutions. This may change without notice. Please see our full disclaimers here:  https://speedwellresearch.com/disclaimer/

Thomas J. Cryan joins us to discuss his new book Disrupting Taxes. He highlights how tariffs historically served as the primary source of U.S. federal revenue until the Civil War, after which income taxes took over. He criticizes the current tax system for its heavy reliance on individual salaries and argued for a more efficient, technology-driven approach. We also touch on the national debt, the need for a balanced budget, and concerns about government spending. Thomas advocates for a system that automatically adjusts tax rates to match expenditures.  We discuss... Thomas J. Cryan shares his background as a writer, attorney, and entrepreneur with a focus on law and economics. Cryan discusses his book Disrupting Taxes, inspired by the upcoming expiration of the Tax Cuts and Jobs Act in 2025. The conversation shifts to the historical role of tariffs, particularly how they funded the U.S. government for its first 70 years. The current tax system disproportionately burdens individuals, with 90% of federal revenue coming from salaries and income. Cryan critiques the self-declaratory nature of income tax, arguing it leads to inefficiencies and inequities. He proposes a 1% automated banking transaction tax to replace income tax and eliminate the IRS. This system would tax all banking transactions equally, spreading the burden more fairly across the economy. A proposed tax system would implement a flat 2% transaction tax, significantly lower than current income tax rates. Government transactions would also be taxed, eliminating loopholes and ensuring transparency in spending versus tax collection. While the system removes the IRS in its current form, some technological oversight would still be needed for enforcement. Low tax rates could discourage avoidance, as the effort to evade 1% taxation may not be worth the hassle. The U.S. tax system must consider global competition to remain economically viable. Tariffs can be an economic tool but may create global trade imbalances and diplomatic tensions. A technology-driven transaction tax system could increase efficiency and fairness over time. Free market principles suggest that supply and demand will eventually create equilibrium despite policy shifts. State and local governments operate under different tax systems, creating challenges in integrating federal tax changes. Broadening the tax base at all levels could lead to lower rates and a fairer system overall. States with high income taxes may consider adopting transaction-based taxation models. For more information, visit the show notes at https://moneytreepodcast.com/disrupting-taxes-thomas-j-cryan-690  Today's Panelists: Kirk Chisholm | Innovative Wealth Barbara Friedberg | Barbara Friedberg Personal Finance Jeff Hulett | Finance Revamp Follow on Facebook: https://www.facebook.com/moneytreepodcast Follow LinkedIn: https://www.linkedin.com/showcase/money-tree-investing-podcast Follow on Twitter/X: https://x.com/MTIPodcast  

In this special episode of Business Trip, co-hosts Greg Kubin and Matias Serebrinsky sit down with Brooks Leitner, the newest partner at PsyMed Ventures, to explore the future of brain and mental health investing. Brooks, an MD/PhD with deep experience from Yale and the NIH, shares his insights on how a human-first approach is reshaping neuroscience innovation and venture investing. In this episode, we discuss:Broadening the Thesis: Evolving from a psychedelics-only focus to a comprehensive neuro investment strategy.Human-First Research: Shifting from animal models to clinical insights for better brain therapies.Key Investment Areas: Therapeutics, medical devices, diagnostics, consumer health, and AI-enabled care platforms.Early-Stage Conviction: Leveraging a prepared mind to spot breakthrough opportunities.Personal & Future Insights: Leadership challenges and the vision for the future of neuro investing.Credits:Created by Greg Kubin and Matias SerebrinskyHost: Matias Serebrinsky & Greg KubinProduced by Jonathan A. Davis,  Nico V. Rey & Caitlin NerFind us at businesstrip.fm and psymed.venturesFollow us on Instagram and Twitter!Theme music by Dorian LoveAdditional Music: Distant Daze by Zack Frank

Derek Moore and Mike Puck talk about the resurgence of international stocks against the US. Plus, how the rest of the market has a similar performance to the Mag 7, indicating a broadening out of stocks in the S&P 500 Index. Later, they discuss what markets historically have done after being up in January and February. Profit margins are rising outside the Mag 7 names and looking at the expected Nvidia move around earnings based upon the implied volatility levels.    S&P 500 Index 493 vs the Mag 7 year to date International stocks including emerging markets and developed markets shine against the US Profit margins continue to rise across the entire S&P 500 Index RSP vs SPY vs EEM vs EFA year to date performance relative to one another Average performance since 1950 for the S&P 500 Index after being up January and February Nvidia options before next week's earnings announcement Calculate expected moves in Nvidia based on implied volatility Pricing the long straddle and short straddle on Nvidia pre-earnings   Mentioned in this Episode     Derek Moore's book Broken Pie Chart https://amzn.to/3S8ADNT   Jay Pestrichelli's book Buy and Hedge https://amzn.to/3jQYgMt   Derek's book on public speaking Effortless Public Speaking https://amzn.to/3hL1Mag   Contact Derek derek.moore@zegainvestments.com       

We still think U.S. equities can outperform in 2025, led by tech, even as Europe's start the year strong. Roelof Salomons, Chief Investment Strategist for the Netherlands at the BlackRock Investment Institute, explains why we're broadening our pro-risk view by upgrading European equities. General disclosure: This material is intended for information purposes only, and does not constitute investment advice, a recommendation or an offer or solicitation to purchase or sell any securities, funds or strategies to any person in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. The opinions expressed are as of the date of publication and are subject to change without notice. Reliance upon information in this material is at the sole discretion of the reader. Investing involves risks. BlackRock does and may seek to do business with companies covered in this podcast. As a result, readers should be aware that the firm may have a conflict of interest that could affect the objectivity of this podcast.In the U.S. and Canada, this material is intended for public distribution.In the UK and Non-European Economic Area (EEA) countries: this is Issued by BlackRock Investment Management (UK) Limited, authorised and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL. Tel:+ 44 (0)20 7743 3000. Registered in England and Wales No. 02020394. For your protection telephone calls are usually recorded. Please refer to the Financial Conduct Authority website for a list of authorised activities conducted by BlackRock.In the European Economic Area (EEA): this is Issued by BlackRock (Netherlands) B.V. is authorised and regulated by the Netherlands Authority for the Financial Markets. Registered office Amstelplein 1, 1096 HA, Amsterdam, Tel: 020 – 549 5200, Tel: 31-20- 549-5200. Trade Register No. 17068311 For your protection telephone calls are usually recorded.For Investors in Switzerland: This document is marketing material.In South Africa: Please be advised that BlackRock Investment Management (UK) Limited is an authorised Financial Services provider with the South African Financial Services Board, FSP No. 43288.In Singapore, this is issued by BlackRock (Singapore) Limited (Co. registration no. 200010143N). This advertisement or publication has not been reviewed by the Monetary Authority of Singapore. In Hong Kong, this material is issued by BlackRock Asset Management North Asia Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong. In Australia, issued by BlackRock Investment Management (Australia) Limited ABN 13 006 165 975, AFSL 230 523 (BIMAL). This material provides general information only and does not take into account your individual objectives, financial situation, needs or circumstances. Before making any investment decision, you should assess whether the material is appropriate for you and obtain financial advice tailored to you having regard to your individual objectives, financial situation, needs and circumstances. Refer to BIMAL's Financial Services Guide on its website for more information. This material is not a financial product recommendation or an offer or solicitation with respect to the purchase or sale of any financial product in any jurisdictionIn Latin America: this material is for educational purposes only and does not constitute investment advice nor an offer or solicitation to sell or a solicitation of an offer to buy any shares of any Fund (nor shall any such shares be offered or sold to any person) in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities law of that jurisdiction. If any funds are mentioned or inferred to in this material, it is possible that some or all of the funds may not have been registered with the securities regulator of Argentina, Brazil, Chile, Colombia, Mexico, Panama, Peru, Uruguay or any other securities regulator in any Latin American country and thus might not be publicly offered within any such country. The securities regulators of such countries have not confirmed the accuracy of any information contained herein. The provision of investment management and investment advisory services is a regulated activity in Mexico thus is subject to strict rules. For more information on the Investment Advisory Services offered by BlackRock Mexico please refer to the Investment Services Guide available at www.blackrock.com/mx©2025 BlackRock, Inc. All Rights Reserved. BLACKROCK is a registered trademark of BlackRock, Inc. All other trademarks are those of their respective owners.BIIM0225U/M-4262744

Welcome to this week's episode of The Happy Mama Movement Podcast.Today, we're joined by the wonderful Nancy Reddy—writer, poet, and writing teacher—whose work explores the often messy, complex realities of motherhood and creativity. Nancy's first book of narrative nonfiction, The Good Mother Myth, is set to be published by St. Martin's in January 2025. She's also the author of three books of poetry, including Pocket Universe, and co-editor of The Long Devotion: Poets Writing Motherhood. Her writing dives into the truths behind the glossy myths we're told about motherhood, and she's been featured in Slate, Romper, and Electric Literature, among others.We explore:The myth of the "Good Mother” and how it shapes our experiencesA New Description and re-definition: Motherhood as a RelationshipHow creativity can survive and thrive amidst the chaos of parentingGuilt, Struggle and Judgement of ourselves as women.Broadening the public conversation around motherhood and parenting.As always, I hope this conversation sparks something in you. If it does, please pass it along to the mothers in your life. We all deserve a little more honesty, support, and solidarity on this wild ride.ABOUT NANCY REDDY: Nancy Reddy is a writer and a writing teacher. Her first book of narrative nonfiction, The Good Mother Myth, is forthcoming from St. Martin's in January 2025. She is the author of three books of poetry, most recently Pocket Universe, and the co-editor of The Long Devotion: Poets Writing Motherhood. Her recent writing includes pieces on the damaging mythology of the “golden hour” after birth for Slate, making mom friends for Romper, and review-essays on the whiteness of the motherhood memoir and the political nature of motherhood at Electric Literature. Nancy holds an MFA in poetry and a PhD in rhetoric and composition, both from the University of Wisconsin-Madison. In a previous academic life, she published scholarly work on writing studies and materiality, creative writing pedagogy, and community literacy in journals such as Community Literacy Journal, Literacy in Composition Studies, and The Journal of Creative Writing Studies.Nancy currently teaches at Stockton University in New Jersey, and she also leads community writing workshops and lifelong learning courses, including at the Cooper Street Writing Workshops at Rutgers-Camden, the Stockton Institute for Lifelong Learning, Blue Stoop, and Murphy Writing. You can find her on Instagram and subscribe to her newsletter, Write More, Be Less Careful, where she offers wisdom and encouragement on navigating the often-difficult writing life.RESOURCES:Instagram: https://www.instagram.com/nancy.o.reddy/NANCY'S NEWSLETTER: Write More, Be Less Careful: https://nancyreddy.substack.com/Website: https://www.nancyreddy.com/BUY THE BOOK: https://www.amazon.com.au/Good-Mother-Myth-Redefining-Motherhood/dp/1580055028UK SHOPPERS BUY THE BOOK HERE: https://www.amazon.co.uk/Good-Mother-Myth-Unlearning-Ideas/dp/1250336643OR HERE: https://www.waterstones.com/book/the-good-mother-myth/nancy-reddy/9781250336644 Hosted on Acast. See acast.com/privacy for more information.

The top-down view in the US on the need for a sustainable approach to business and government has shifted, but there are still signs that initiatives on greater diversity, equity and inclusion can persist. Alex tells Chief Market Strategist Daniel Morris that talk of the end of sustainable investing is premature: New solutions will be developed and existing processes refined.For more insights, visit Viewpoint: https://viewpoint.bnpparibas-am.com/Download the Viewpoint app: https://onelink.to/tpxq34Follow us on LinkedIn: https://bnpp.lk/amHosted by Ausha. See ausha.co/privacy-policy for more information.

"Lung transplantation is always exciting. But it will be even more in the future!" Leaders in the transplantation field and well-regarded ERS Officers, Michael Perch and Federica Meloni, join Dorina Esendagli in a podcast focusing on the latest Monograph: Lung Transplantation. Covering the formidable topics of immunosuppressive treatment and post-transplant care, it is clear that both the podcast and book are hugely relevant to the transplant specialist. However, Michael and Federica explain that the book is also aimed at specialists in other areas of pneumology, as well as general physicians from beyond the respiratory field. Broadening understanding about this challenging area is essential if we are to improve prognosis and widen donor availability.

In this episode, I uncover the real reasons why your videos aren't getting the views they deserve and show you exactly how to fix it. Most creators think it's about algorithms, but the truth is, engagement, structure, and relevance play a much bigger role. I break down how to optimize your content, keep viewers hooked, and make sure your videos are seen by the right audience. Whether you're struggling with low views or want to improve retention, this episode will give you the tools to level up your video strategy.In this episode, we discuss:[00:05] Introduction: Why getting more views isn't just about the algorithm.[01:19] The guessing game: Why throwing out random content rarely leads to consistent success.[03:12] Reverse engineering viral videos: How to analyze what works in your niche.[05:09] Relevance over value: Why even great content fails if it's not timely and targeted.[08:23] Broadening your niche: Expanding your content while keeping it aligned with your audience's interests.[12:02] Creating binge-worthy content: How to build a library of videos that keep people coming back.[16:19] Research strategies: Using platforms like TikTok, YouTube Shorts, and Instagram to identify trends.[20:32] The power of testing different hooks, structures, and storytelling methods.[27:03] How your past content influences your future reach and engagement.[34:27] Objective feedback: Why you need an outside perspective to refine your videos.-------Thanks for listening! Here's what you need to do next

Have you ever thought your photography is getting stale? Have you ever found yourself in a photographic rut? We have, and in this episode we are talking about ways to get around that by trying something new.  Pixelfed Greg's Book The Podcast Website Dave on Instagram Dave on Threads Dave on Bluesky Dave on X Dave on TikTok Dave on VERO Dave on Mastodon Dwight on Flickr Dwight on VERO Dwight on Glass Dwight on Instagram Dwight's Art on Instagram Dwight on VSCO Greg on About.me Greg on Instagram Greg on Threads Greg on Bluesky Greg on Glass Greg on VERO Greg on Flickr Greg on Twitter Greg's Website Greg on Mastodon The Podcast YouTube Channel Shayne Mostyn's YouTube Channel Smartphone Photography Club Smartphone Photography Club Forum The iPhoneography Podcast Facebook Group Shayne Mostyn's Bloody Legends Facebook Group Rick Sammon's Smartphone Photo Experience Facebook Group Reeflex's Facebook Group Get your first year of Glass for $20: https://glass.photo/offer/greg Reeflex Lenses - Get 10% off Reeflex lenses with the coupon code 10%OFFGREG Buy me a coffee at https://www.buymeacoffee.com/mcmillan The music at the end of this video was created on a Mac using GarageBand.

Kevin Green says he's "not too concerned about the market yet," pointing to a broadening market as one factor preventing further selling action. However, he notes weakness in Big Tech with Nvidia (NVDA) and Microsoft (MSFT) testing their 200-day SMA. Kevin points to bullish signs he still sees in the days ahead. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Sepsis rarely attracts the attention of the public, but it's distressingly common: Every year, about 1.7 million U.S. adults develop this overreaction to infection — and more than 350,000 of them die. On this bonus episode of 20-Minute-Health-Talk, you'll hear the stories of doctors and patients fighting against this subtle yet deadly condition, and how the battle led to a global alliance to combat the silent killer. You'll also hear how pioneering research and lifesaving protocols developed at the Feinstein Institutes for Medical Research and Northwell Health have reduced sepsis-related deaths — both within their hospitals, throughout New York State, and around the world. Chapters 00:01 — Intro 00:53 — What is sepsis? 02:23 — 1985: A loss and a mission 03:36 — 2005: Assembling a team 06:08 — 2010: Launching a global alliance 06:52 — 2011: A better process 07:13 — 2012: Turning tragedy into action 08:46 — 2014: Early signs of success 10:09 — 2018: Watching the tide turn 11:06 — 2019: Broadening the effort to fight sepsis 11:34 — 2021: Tackling maternal sepsis 12:03 — 2023 and beyond: Ending sepsis 13:27 — Outro About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

The UK Investor Magazine was delighted to welcome Rick Guiney, CEO of MicroSalt, back to the podcast to review the low-sodium salt company's progress in 2024 and outline what investors can expect in 2025.We start with a review of the progress the company made in 2024 following MicroSalt's IPO in February 2024. Rick provides an overview of recent developments, including the launch of ‘MicroSalt Premium' and the inroads the company is making with new applications, including French fries, in the fast food industry.We conclude with a rundown of what investors have to look forward to in the year ahead. Hosted on Acast. See acast.com/privacy for more information.

Scott Wapner and the Investment Committee debate the best way to play this bull market. The panel reacts to President Trump's address to world economic leaders at Davos. The experts detail their latest portfolio moves. Josh Brown updates his best stocks in the market list. Investment Committee Disclosures

In this episode, I dive into the reasons why most content fails to gain traction and how you can reverse engineer virality to create content that resonates with your audience. By analyzing proven strategies, identifying what's working in your niche, and understanding the importance of relevance, I'll show you how to stop guessing and start crafting content with purpose. Whether you're struggling with low views or inconsistent engagement, this episode is packed with actionable tips to help you grow.In this episode, we discuss:[00:05] Introduction: Why most creators struggle with engagement and how to overcome it.[01:19] The guessing game: How creating untested ideas leads to inconsistent results.[03:12] Reverse engineering attention: Learning from viral content in your niche.[05:09] Relevance over value: Why even valuable content fails without timely appeal.[08:23] Broadening your niche to increase potential reach and avoid overly niche topics.[12:02] Building a library of binge-worthy content to create trust and familiarity.[16:19] Research tips: Using TikTok and other platforms to find the most liked and relevant content.[20:32] Testing hooks, structures, and formats to refine what works for your audience.[27:03] The role of the algorithm: How your account's history influences future virality.[34:27] Objective feedback: Why you need a third-party perspective to fine-tune your content.-------Thanks for listening! Here's what you need to do next

Hal Herring is an award-winning outdoor journalist, fierce public lands advocate, and thoughtful, action-oriented conservationist. He's also an accomplished podcaster and host of Backcountry Hunters and Anglers' Podcast & Blast with Hal Herring. If you're a longtime listener of Mountain & Prairie, you may remember my first episode with Hal back in December of 2019– pre-pandemic, when the world was a much different place. Like me, Hal was born and raised in the south, and also like me, his Southern accent has not faded. But he's made Montana his home for many decades now and has established himself as one of the most respected voices in conservation here in the American West. This episode was recorded live and on stage at the 2024 Old Salt Festival on the Mannix Family Ranch in Helmville, Montana. If you're not familiar with Old Salt, it's a three-day gathering in Montana's Blackfoot Valley that combines live Americana music with artists like Sterling Drake and Summer Dean, wood-fired cooking with chefs including Eduardo Garcia, and a General Store featuring western makers such as Cate Havstad, Jillian Lukiwski, Christy Sing, and many more. The festival also includes a ton of on-stage conversations about land stewardship, conservation, history, literature, and more– and this is one of those conversations. Most of you are probably already familiar with Hal, but if you're not, you are in for a treat. Hal brings such energy, humor, and knowledge to everything he does, and he has personally helped me in my own personal journey to better understand this complex region known as the American West. In this conversation, we covered a lot, including: Hal's journey from Alabama to Montana, his thoughts on the current state of family ranching and public lands, optimism vs pessimism, and who he admires in the conservation space. We also discuss his forthcoming book on public lands, an idea he is working on for a new podcast, and we take a number of questions from the audience. I know you'll learn a lot from this episode– I consider Hal a great teacher and leader, and it's always an honor to spend time with him. Tickets for the 2025 Old Salt Festival are on sale now, so follow this link to learn more and secure your spot at what will surely be another amazing weekend with amazing people. Thanks to Hal for the conversation, to the Mannix Family for opening up their ranch for this festival, and to you for listening! --- Hal Herring Backcountry Hunters and Anglers' Podcast & Blast with Hal Herring Old Salt Festival Hal's first M&P episode Full episode notes and links: https://mountainandprairie.com/hal-herring-2/ --- TOPICS DISCUSSED: 3:30 - Ed introducing Hal at Old Salt Festival 4:45 - How Hal ended up in Montana 7:15 - Hal's thoughts on the consolidation, absorption of family ranches 9:30 - Threat to public lands  11:15 - Hal's “ah ha” moments as he's researching his new book 12:45 - Hal's book recs 15:00 - Finding common ground 18:15 - Keeping the energy going  19:15 - Hal's new podcast project  23:45 - What Hal views as current threats to public lands (1872 mining law) 26:00 - Optimist or pessimist? 29:15 - Who's taking action? 31:45 - Start of Q&A, Hal expanding on new podcast 34:00 - Broadening the audience 36:00 - What's Hal doing beyond podcasting to trigger improvement? 37:15 - Ideas into action 39:00 - Project 2025 42:15 - Getting people's attention without scaring them 44:00 - Future of journalism 46:00 - Montana Senate race --- ABOUT MOUNTAIN & PRAIRIE: Mountain & Prairie - All Episodes Mountain & Prairie Shop Mountain & Prairie on Instagram Upcoming Events About Ed Roberson Support Mountain & Prairie Leave a Review on Apple Podcasts

In today's episode, I share practical strategies for staying current in the ever-changing legal landscape, even when billable hours and client demands dominate your schedule.  I discuss how to create a system for digesting critical legal updates, leveraging firm and external resources for professional development, and connecting with colleagues to maximize learning opportunities.  Whether it's identifying efficient ways to track industry news or tapping into events and partnerships to expand expertise, this episode offers actionable advice for lawyers aiming to maintain their edge in large law firms.  At a Glance: 0:00 Introduction: Why professional development is critical for lawyers at every stage 0:23 The challenge of balancing professional growth with the demands of big law 2:03 Efficient ways to audit and organize legal updates in your practice area 3:23 Using competitor resources and external publications for legal insights 4:26 Broadening your knowledge through business and industry news 5:35 Leveraging webinars and hybrid conferences to keep learning accessible 7:00 Maximizing value from bar associations and local events 7:45 Opportunities in internal firm-sponsored events and panels 8:47 Collaborating with colleagues to streamline learning and share expertise 10:19 Building relationships with senior colleagues for mentorship and mutual growth 12:12 Final thoughts on balancing professional development with client demands Rate, Review, & Follow on Apple Podcasts & Spotify Do you enjoy listening to Big Law Life?  Please consider rating and reviewing the show! This helps support and reach more people like you who want to grow a career in Big Law.  For Apple Podcasts, click here, scroll to the bottom, tap to rate with five stars, and select “Write a Review.” Then be sure to let me know what you loved most about the episode! Also, if you haven't done so already, follow the podcast here!  For Spotify, tap here on your mobile phone, follow the podcast, listen to the show, then find the rating icon below the description, and tap to rate with five stars. Interested in doing 1-2-1 coaching with Laura Terrell? Or learning more about her work coaching and consulting? - here are ways to reach out to her: www.lauraterrell.com  laura@lauraterrell.com   LinkedIn: https://www.linkedin.com/in/lauralterrell/  Instagram: https://www.instagram.com/lauraterrellcoaching/  Show notes: https://www.lauraterrell.com/podcast  

Jeffrey Kleintop and Nathan Peterson join today's Charles Schwab Big Picture panel to talk about today's "relief rally." Nathan notes the stock bump as a positive but warns against elevated volatility as CPI shows inflation bumps over 0%. Jeff says that can also play into earnings, calling Citigroup's (C) $20 billion share buyback plan a potential outlier due to inflation. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

In this podcast episode, Dr. Jonathan H. Westover talks with Dr. Rosalind Cohen about broadening how people view commonalities to create cultures of inclusion and belonging. Dr. Rosalind Cohen (a.k.a. Dr. Roz) (https://www.linkedin.com/in/rosalindfcohen/) is an entrepreneur, speaker, author, and a “Connectifier” who helps organizations build inclusive, radically connected cultures of belonging that benefit individuals and drive business growth. A rising thinker in the worlds of belonging and inclusion, Dr. Roz earned her PhD from the Leadership and Change program at Antioch University, completing her dissertation on the impact of inclusive leadership on employee engagement and organizational success. Founder of Socius Strategies, a private inclusion and belonging advisory practice, Dr. Roz spent 20+ years in HR at the C-level before making the leap to entrepreneurship. Today, she gives talks across the U.S., is an Advisor to NASA, and is the author of a forthcoming book that answers the question, “Is there a connection between inclusive leadership, employee engagement, and organizational success?” (Spoiler alert: there is!) Dr. Roz Cohen is anything but your traditional HR lady.  Check out all of the podcasts in the HCI Podcast Network!

In this week's episode, Todd provides an update on the market and discusses the potential for market participation to broaden out in 2025. Click here to view supporting charts referenced in today's episode.

Angela talks to Tommy Wood about the intriguing relationship between exercise and cognitive function, exploring how different forms of physical activity can enhance creativity, focus, and overall mental clarity. They discuss personal experiences with exercise, such as the rhythmic nature of strength training and its impact on idea generation. They also look at research findings that suggest various types of exercise, from aerobic to resistance training, can improve aspects of working memory and executive function, particularly when not taken to the point of exhaustion KEY TAKEAWAYS Movement Benefits Cognitive Function: Moderate-intensity exercise boosts focus, memory, and creativity. Lactate and Neurotrophic Factors: Physical activity increases lactate, stimulating brain-derived neurotrophic factor (BDNF), which supports brain health. NSDR and Walking: Practices like NSDR or walking in nature reduce stress, promote relaxation, and consolidate learning. Energy Management: Short bursts of movement during the workday refresh focus and productivity. TIMESTAMPS AND KEY TOPICS 0:05 – Broadening perspective with movement and mindfulness. 1:56 – The connection between exercise and cognitive clarity. 4:15 – Exercise types that support creativity and focus. 6:39 – Benefits of moderate exercise without exhaustion. 9:02 – Distraction-free movement aids creative thinking. 13:03 – Optimal productivity window after exercise. 14:33 – Breaking up the day with short bouts of movement. 16:19 – NSDR vs. walking for brain benefits. 17:51 – Relaxation enhances memory consolidation. VALUABLE RESOURCES Get a free snapshot of your health and personalised report at www.yourtotalhealthcheck.com Join The High Performance Health Community Use code ANGELA at oneskin.co/angela for 15% off your purchase Visit Just Thrive and use CODE ANGELA20 at www.justthrivehealth.com Link to full episode 349 - https://omny.fm/shows/high-performance-health/neuroscience-upgrade-and-protect-your-brain-with-d One Skin Limited Edition Christmas Bundle - $99 (Value $149) - save 15% with code ANGELA at oneskin.co/angela CONTACT DETAILS Instagram Facebook LinkedIn Affiliate Disclaimer: Note this description contains affiliate links that allow you to find the items mentioned in this video and support the channel at no cost to you. While this channel may earn minimal sums when the viewer uses the links, the viewer is under no obligation to use these links. Thank you for supporting the show! Disclaimer: The High Performance Health Podcast is for general information purposes only and do not constitute the practice of professional or coaching advice and no client relationship is formed. The use of information on this podcast, or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for medical or other professional advice, diagnosis, or treatment. Users should seek the assistance of their medical doctor or other health care professional for before taking any steps to implement any of the items discussed in this podcast.

On today's show Andrew and Bill begin with the latest messaging from Beijing on efforts to stimulate the economy in 2025 and beyond. Topics include: Politburo language that echoes 2008, muted reactions from the mainland markets, why the ultimate policy decisions may not be made until the PRC has more clarity on Trump's intentions, and more. From there: Nvidia finds itself at the center of an antitrust probe, while the PRC restrictions on critical minerals are broader than initially thought, and drone components are now also being restricted from export to the US and Europe. At the end: Reviewing last Friday's verdict from the DC Circuit in TikTok v. Garland, and charting the next steps for TikTok and the Trump administration as January 19th approaches and TikTok faces a ban in the United States.

November 22, 2024 - The Van Fleet Signature Policy Conference is The Korea Society's landmark policy event. Held in the District Ballroom of The Mayflower Hotel in Washington D.C., the conference provides insights on the fast evolving threats and opportunities impacting the dynamic U.S.-Republic of Korea (ROK) relationship, including a panel on security, a panel on diplomacy, and a keynote address. The diplomacy panel, “A Broadening U.S.-ROK Relationship in a Changing Regional and Global Landscape,” is moderated by Amb (Ret.) Kathleen Stephens and features former ROK Foreign Minister Yun Byung-se, Dr. Victor Cha, and Dr. Katrin Katz. Policy director Jonathan Corrado and Policy program officer Chelsie Alexandre are emcees. For more information, please visit the link below: https://www.koreasociety.org/policy-and-corporate-programs/item/1882-u-s-rok-indispensable-partnership-amid-increasing-geopolitical-competition

In the latest LPL Market Signals podcast, LPL Research's Chief Equity Strategist, Jeffrey Buchbinder, is joined by Chief Technical Strategist Adam Turnquist, as they recap last week's strong bounce back for stocks, highlight the improving market breadth, and provide some perspective on market concentration. Stocks rose solidly last week, rising all five days. It wasn't about the mega-caps this week as a broadening out lifted large cap equity benchmarks. The strategists reviewed several charts and discussed how broad participation underpinned the latest breakout to new highs on the S&P 500. They highlight how this rotation has also been evident in small caps but note the current technical evidence does not yet support a shift toward sustainable outperformance of small caps over large caps. Given the uptick in interest rate volatility, they also discuss the technical setup for 10-year Treasury yields, including key support and resistance levels. Next, the strategists provide historical perspective on the high degree of concentration in the stock market today. The shift toward passive investments has been a big reason why. Concentration by itself isn't a reason for a market correction, but it could amplify an eventual selloff. The strategists wrap up with a preview of the week ahead. Minutes from the November Fed meeting, the Fed's preferred inflation metric, and a big batch of Treasury auctions will keep markets focused on interest rates. Tracking: #663336

Nov 22, 2024 – Financial Sense Newshour welcomes MarketGauge's Chief Strategist, Mish Schneider, to discuss the big moves that took place in the market this week. Mish explains how we are seeing a broadening of the stock market rally...

Send us a text

Financial markets had, perhaps, hoped that the next US treasury secretary would serve as a defender of free trade in the administration, and at least seek to minimize the severity of US consumer tax hikes. Media reports suggest that the search is being broadened, and commitment to the tax increases is being sought. The challenge of the proposed tariffs is not just the rate, but also the breadth (and the possibility of universal blanket tariffs).

Welcome to the YOU CAN CALL ME “BOSSY” PODCAST! CLICK HERE to book your FREE 1:1 Clear it the F*CK Out Call to clear a block or fear holding you back! In this quick hit episode, I am getting into all about—money, honey. We'll explore how our mindsets around money shape our lives, the importance of acknowledging those uncomfortable emotions, and harnessing your power instead of giving it away.Get ready to challenge limiting beliefs, especially if you've been told that wanting more money is wrong or that there's only so much you can earn in certain careers. We'll discuss the paradigm shift from seeing money as scarce to recognizing it as an abundant resource, crucial for safety, freedom, and making a positive impact in the world. And don't forget, if you're not yet part of the club, now's the time to join and gain access to transformative workshops on money mindset. So, tune in, and let's reshape your financial future together. Key Takeaways: Focusing on money for security and empowerment Broadening the understanding of money beyond just a bank account number Challenging the mindset of limited access to money If you enjoyed this episode and are excited for more, please be sure to SUBSCRIBE and write a review to help build momentum and support the show (5-stars would be AWESOME!) _____________________________________________ JOIN US IN - THE CLUB - An annual membership where high-achieving women come together to unapologetically OWN THEIR “BOSSY” in order to rise to the top, make massive impact, and not burn out while doing it. Join TODAY to get access to all past workshop replays and past group coaching calls - always incredible takeaways and AHA moments from reviewing these sessions! Grab your spot in THE CLUB today by CLICKING HERE! _____________________________________________ LET'S FREAKING GO!GRAB THIS FREE DOWNLOAD: GRAB 100 FREE JOURNAL PROMPTS TO OWN YOUR BOSSY BY CLICKING HERE LET'S CONNECT: Follow me on Instagram, LinkedIn, TikTok, or join my STAND IN YOUR POWER FACEBOOK GROUP Grab a signed copy of my bestselling book STAND IN YOUR POWER HEREWatch my TEDx Talk “The Wisdom of Your Ancestors Should Be Ignored” HERE

Last week's post-election rally continued today, and Kevin Green notes small and mid-caps are reaping more of the benefits. However, there could be disruption from economic prints later this week. Kevin breaks down trends to watch with the VIX. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Joe Tigay weighs in on Palantir (PLTR) earnings and the post-earnings surge in the A.I. software stock. He says they "had a fantastic top line number" but points to the sticky customer count as a better metric to track this company's growing role in the A.I. trade. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

The last few weeks have seen spectacular weather in New England, with warm temperatures and blue skies almost every day. By now, we would normally have stored the back-yard furniture inside to prevent it getting ruined over the winter. But instead, on weekend afternoons, Sari and I drowsily read our books in the sunshine with the still-loud chirping of the crickets letting us pretend that summer isn't really over. Nor is there any harsh weather in the near-term forecast – it should be in the 70s on Thursday when the trick-or-treaters set off on their rounds. But the gentle rustle of falling leaves is providing its usual warning of colder days ahead and the need to be prepared.

IMTS is where manufacturing's cutting-edge technology takes center stage, and this year was no exception. IMTS 2024 brought the future to the forefront, showcasing the most advanced solutions in the industry. In this episode of MakingChips, Nush Ahmed and Chris Luecke join Paul, Nick, and Mike to dive into the game-changing technologies that caught their attention—from additive manufacturing and 3D printing to machine monitoring, automation, robotics, and beyond. If you're a manufacturing leader who's serious about staying at the forefront of technology, you need to know what's shaping the industry. Ttune in to catch up on the innovations that are pushing the boundaries of what's possible in manufacturing. Segments [2:05] Introducing Nush Ahmed and Chris Luecke [4:13] Our favorite innovations showcased at IMTS 2024 [10:43] Broadening the appeal of manufacturing [12:41] Why you need ProShop ERP in your shop [18:45] The innovation happening in software  [21:40] The innovation happening in communications and marketing Resources mentioned on this episode Connect with Nush Ahmed Connect with Chris Luecke Manufacturing Happy Hour  Within Tolerance Podcast Leela AI Toolpath Datanomix Paperless Parts Connect With MakingChips www.MakingChips.com On Facebook On LinkedIn On Instagram On Twitter On YouTube